University of Sydney
Proteomic Map of Hundreds of Cancer Cell Lines Helps Discover New Biomarkers
Integration of multiomics, drug response, and CRISPR gene essentiality data with deep learning analysis uncovered biomarkers of cancer vulnerabilities.
Multiomic Profiling Uncovers Predictors of Melanoma Response to Immunotherapy
A model based on the results could predict treatment response but was less able to forecast resistance, suggesting heterogeneous mechanisms.
University of Sydney Wins A$1.4M Grant, Teams With Allelica on Cardiac Polygenic Risk Scores
Researchers at the University of Sydney will work with Allelica to develop polygenic risk scores for coronary artery disease prevention and integrate the testing into primary care.
Measles Virus Diverged From Related Cow Pathogen Around Sixth Century BC, Sequencing Study Finds
The timing of the divergence of the Measles morbillivirus and Rinderpest morbillivirus lineages traces to about when human populations began to live in cities.
Melanoma BRAF Mutation Type May Affect Response to Targeted Treatments, Immunotherapy
In a small study, melanoma patients with BRAF V600K mutations responded better to immunotherapy while those with V600E mutations had a better response to targeted therapy.